Based on the pioneering research of Intra-Cellular Therapies co-founder and Nobel laureate, Dr. Paul Greengard, we developed a detailed understanding of intracellular signaling pathways and targets.
Drug discovery efforts are complemented by CNSProfile™, our novel, proprietary platform based on Nobel prize-winning science
We are using this knowledge to develop technology platforms including CNSProfile™, which we use to validate our selection of drug candidate molecules.